Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 30th, there was short interest totaling 49,980 shares, a decrease of 53.4% from the January 15th total of 107,279 shares. Based on an average trading volume of 7,302,732 shares, the days-to-cover ratio is currently 0.0 days. Approximately 6.8% of the company’s stock are sold short. Approximately 6.8% of the company’s stock are sold short. Based on an average trading volume of 7,302,732 shares, the days-to-cover ratio is currently 0.0 days.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aditxt in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Aditxt presently has an average rating of “Sell”.
Read Our Latest Research Report on ADTX
Aditxt Stock Performance
About Aditxt
Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.
The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.
See Also
- Five stocks we like better than Aditxt
- ALERT: Drop these 5 stocks before January 2026!
- Buy This Stock Now
- Trump Planning to Use Public Law 63-43: Prepare Now
- Trump & Musk’s Secret Bet on Silver — Exposed
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
